Phenoxymethylpenicillin-AFT (Penicillin V) now in Australia

In addition to the four products on the Pharmaceutical Schedule, Budenocort Powder for Inhalation, Aramed, Acetadote IV and Provive MCT-LCT. Australia, AFT Pharmaceuticals is delighted to achieve further PBS listings to the four listed, Phenoxymethylpenicillin-AFT (Penicillin V) Oral Liquid 125mg/5ml & 250mg/5ml strengths on the PBS from 01 June 2011.

This restores the original penicillin oral liquid strengths to the PBS adding to choice available to Australian doctors and patients.

“These new listings will add to AFT’s extensive list of products on the Pharmaceutical Schedule”, said CEO and founder Dr Hartley Atkinson.

November 20, 2025

AFT delivers 10th consecutive first half revenue increase

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…

Read More

November 12, 2025

AFT Pharmaceuticals Brings Next-Generation Liposomal Collagen and Wellness Range to the U.S. Market 

AFT Pharmaceuticals has launched its full Lipo-Sachets® range in the U.S., featuring advanced collagen and vitamin supplements powered by patented LI…

Read More

September 25, 2025

On track for $300m FY27 revenue; positive iron IV study result

– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …

Read More